[HTML][HTML] Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice

FS Oladunni, JG Park, PA Pino, O Gonzalez… - Nature …, 2020 - nature.com
Vaccine and antiviral development against SARS-CoV-2 infection or COVID-19 disease
would benefit from validated small animal models. Here, we show that transgenic mice …

COVID‐19–associated Guillain‐Barré syndrome: The early pandemic experience

JB Caress, RJ Castoro, Z Simmons, SN Scelsa… - Muscle & …, 2020 - Wiley Online Library
Guillain‐Barré syndrome (GBS) is an inflammatory polyradiculoneuropathy associated with
numerous viral infections. Recently, there have been many case reports describing the …

[HTML][HTML] Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study

N Hoertel, M Sánchez-Rico, R Vernet, N Beeker… - Molecular …, 2021 - nature.com
A prior meta-analysis showed that antidepressant use in major depressive disorder was
associated with reduced plasma levels of several pro-inflammatory mediators, which have …

COVID-19, mast cells, cytokine storm, psychological stress, and neuroinflammation

D Kempuraj, GP Selvakumar, ME Ahmed… - The …, 2020 - journals.sagepub.com
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is a new pandemic infectious disease that originated in China …

[HTML][HTML] Humoral responses and serological assays in SARS-CoV-2 infections

Y Galipeau, M Greig, G Liu, M Driedger… - Frontiers in …, 2020 - frontiersin.org
In December 2019, the novel betacoronavirus Severe Acute Respiratory Disease
Coronavirus 2 (SARS-CoV-2) was first detected in Wuhan, China. SARS-CoV-2 has since …

Pathophysiology of COVID-19: mechanisms underlying disease severity and progression

MK Bohn, A Hall, L Sepiashvili, B Jung… - …, 2020 - journals.physiology.org
The global epidemiology of coronavirus disease 2019 (COVID-19) suggests a wide
spectrum of clinical severity, ranging from asymptomatic to fatal. Although the clinical and …

Laboratory findings in COVID-19 diagnosis and prognosis

A Pourbagheri-Sigaroodi, D Bashash, F Fateh… - Clinica chimica acta, 2020 - Elsevier
Background Since its first description, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), formerly known as 2019-nCoV, has attracted tremendous attention in a short …

[HTML][HTML] How can nanotechnology help to combat COVID-19? Opportunities and urgent need

EVR Campos, AES Pereira, JL De Oliveira… - Journal of …, 2020 - Springer
Incidents of viral outbreaks have increased at an alarming rate over the past decades. The
most recent human coronavirus known as COVID-19 (SARS-CoV-2) has already spread …

[HTML][HTML] Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients

RM Elshazli, EA Toraih, A Elgaml, M El-Mowafy… - PloS one, 2020 - journals.plos.org
Objective Evidence-based characterization of the diagnostic and prognostic value of the
hematological and immunological markers related to the epidemic of Coronavirus Disease …

[HTML][HTML] Neurological complications and infection mechanism of SARS-COV-2

D Wan, T Du, W Hong, L Chen, H Que, S Lu… - Signal Transduction and …, 2021 - nature.com
Abstract Currently, SARS-CoV-2 has caused a global pandemic and threatened many lives.
Although SARS-CoV-2 mainly causes respiratory diseases, growing data indicate that SARS …